cytarabine has been researched along with Myocardial Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Forsch, S; Janssens, U; Niedeggen, A; Staib, P | 1 |
| Gallet, B; Genet, P; Jondeau, K; Laribi, K; Lionnet, F; Pulik, M; Touahri, T | 1 |
2 other study(ies) available for cytarabine and Myocardial Ischemia
| Article | Year |
|---|---|
[Percutaneous coronary intervention in a patient with acute myeloid leukemia].
Topics: Angioplasty, Balloon, Coronary; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Coronary Angiography; Cytarabine; Female; Heart Failure; Humans; Leukemia, Myeloid, Acute; Lymph Nodes; Middle Aged; Mitoxantrone; Mitral Valve Insufficiency; Myocardial Infarction; Myocardial Ischemia; Platelet Aggregation Inhibitors; Platelet Transfusion; Remission Induction; Stents; Thrombocytopenia | 2012 |
Acute myocardial ischemia after high-dose therapy with BEAM regimen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Immunoblastic Lymphadenopathy; Melphalan; Middle Aged; Myocardial Ischemia; Peripheral Blood Stem Cell Transplantation; Transplantation, Autologous | 2002 |